Heart rate control for permanent atrial fibrillation and heart failure
Part of Heart & circulation clinical trials.
This trial studies whether a strategy to regularize (control) heart rate can improve outcomes in people who have permanent atrial fibrillation and heart failure. It focuses on people with recent heart-failure hospitalization and checks several heart, kidney, and health-condition limits to keep the study safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have permanent atrial fibrillation (a lasting irregular heart rhythm).
- You were hospitalized for heart failure at least once in the last 12 months.
- Your heart pumping strength is above 40% (left ventricular ejection fraction > 40%).
- Your resting heart rate is 110 beats per minute or lower.
- Your NT-proBNP blood test is at least 900 in the past 30 days.
- You’re 18 or older and able to understand the study and consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two procedures for people who have both atrial fibrillation (AFib) and heart failure: one that slows the heart's electrical signals (AV node ablation) and one that helps the heart pump in a more coordinated way (cardiac resynchronization). Both are options when medications alone aren't enough, and the goal is to improve symptoms and quality of life.
This study compares two treatments for people with atrial fibrillation and heart failure: one is a procedure to fix the irregular heartbeat (AF ablation), and the other involves a different type of pacing for the heart. It aims to find which approach helps you feel better and stay out of the hospital.
This study tests a new way to pace the heart (using a specific spot called the Bachmann bundle) to prevent new episodes of atrial fibrillation (an irregular heartbeat) in people with heart failure who already need a pacemaker or defibrillator. The goal is to keep the heart's rhythm more stable and reduce the risk of future heart rhythm problems.
This trial tests if a pacemaker plus an ablation procedure can improve heart failure symptoms in people with atrial fibrillation. It is for those with moderate to severe heart failure who are already on the right medications.
This trial tests a special way to pace the heart and a procedure to quiet the irregular rhythm in people with advanced heart failure and long-standing atrial fibrillation. It may help improve symptoms and heart function, possibly reducing the need for a transplant.
This trial tests a new type of pacemaker for people with atrial fibrillation who are scheduled for a procedure that disconnects the heart's natural electrical pathway. It may help improve symptoms and heart function.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.